1 Min Read
April 25 (Reuters) - Replicel Life Sciences Inc
* Replicel Life Sciences Inc - United States patent issued to Replicel for its novel dermal injection technologies Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.